Follow
DAMY Thibaud
DAMY Thibaud
Cardiologist - Consultant, Henri Mondor Academic Hospital, University Paris XIIde Médecine de
Verified email at aphp.fr - Homepage
Title
Cited by
Cited by
Year
Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy
MS Maurer, JH Schwartz, B Gundapaneni, PM Elliott, G Merlini, ...
New England Journal of Medicine 379 (11), 1007-1016, 2018
18922018
Nonbiopsy diagnosis of cardiac transthyretin amyloidosis
JD Gillmore, MS Maurer, RH Falk, G Merlini, T Damy, A Dispenzieri, ...
Circulation 133 (24), 2404-2412, 2016
16302016
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart …
AP Maggioni, SD Anker, U Dahlström, G Filippatos, P Ponikowski, ...
European journal of heart failure 15 (10), 1173-1184, 2013
7752013
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
P Garcia-Pavia, C Rapezzi, Y Adler, M Arad, C Basso, A Brucato, ...
European heart journal 42 (16), 1554-1568, 2021
5682021
A new staging system for cardiac transthyretin amyloidosis
JD Gillmore, T Damy, M Fontana, M Hutchinson, HJ Lachmann, ...
European heart journal 39 (30), 2799-2806, 2018
4992018
Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)
MS Maurer, M Hanna, M Grogan, A Dispenzieri, R Witteles, B Drachman, ...
Journal of the American College of Cardiology 68 (2), 161-172, 2016
4182016
Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis
MS Maurer, S Bokhari, T Damy, S Dorbala, BM Drachman, M Fontana, ...
Circulation: Heart Failure 12 (9), e006075, 2019
4152019
Effects of patisiran, an RNA interference therapeutic, on cardiac parameters in patients with hereditary transthyretin-mediated amyloidosis: analysis of the APOLLO study
SD Solomon, D Adams, A Kristen, M Grogan, A González-Duarte, ...
Circulation 139 (4), 431-443, 2019
4002019
Increased neuronal nitric oxide synthase-derived NO production in the failing human heart
T Damy, P Ratajczak, AM Shah, E Camors, I Marty, G Hasenfuss, ...
The Lancet 363 (9418), 1365-1367, 2004
3162004
Cardiac amyloidosis: updates in diagnosis and management
D Mohty, T Damy, P Cosnay, N Echahidi, D Casset-Senon, P Virot, ...
Archives of cardiovascular diseases 106 (10), 528-540, 2013
2792013
Screening for transthyretin amyloid cardiomyopathy in everyday practice
RM Witteles, S Bokhari, T Damy, PM Elliott, RH Falk, NM Fine, ...
JACC: Heart Failure 7 (8), 709-716, 2019
2702019
Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week
J Ternacle, L Krapf, D Mohty, J Magne, A Nguyen, A Galat, R Gallet, ...
Journal of the American College of Cardiology 74 (21), 2638-2651, 2019
2292019
Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness
T Damy, B Costes, AA Hagčge, E Donal, JC Eicher, M Slama, A Guellich, ...
European heart journal 37 (23), 1826-1834, 2016
2212016
Acute heart failure congestion and perfusion status–impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure …
O Chioncel, A Mebazaa, AP Maggioni, VP Harjola, G Rosano, C Laroche, ...
European journal of heart failure 21 (11), 1338-1352, 2019
2162019
Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years
B Iung, X Armoiry, A Vahanian, F Boutitie, N Mewton, JN Trochu, ...
European journal of heart failure 21 (12), 1619-1627, 2019
2102019
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D iseases
P Garcia‐Pavia, C Rapezzi, Y Adler, M Arad, C Basso, A Brucato, ...
European journal of heart failure 23 (4), 512-526, 2021
2082021
Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure
T Damy, KM Goode, A Kallvikbacka-Bennett, C Lewinter, J Hobkirk, ...
European heart journal 31 (18), 2280-2290, 2010
2042010
Causes and consequences of longitudinal LV dysfunction assessed by 2D strain echocardiography in cardiac amyloidosis
J Ternacle, D Bodez, A Guellich, E Audureau, S Rappeneau, P Lim, ...
JACC: Cardiovascular Imaging 9 (2), 126-138, 2016
1962016
High prevalence of iron deficiency in patients with acute decompensated heart failure
A Cohen‐Solal, T Damy, M Terbah, S Kerebel, JP Baguet, O Hanon, ...
European journal of heart failure 16 (9), 984-991, 2014
1832014
Current aspects of the spectrum of acute heart failure syndromes in a real‐life setting: the OFICA study
D Logeart, R Isnard, M Resche‐Rigon, MF Seronde, P de Groote, ...
European journal of heart failure 15 (4), 465-476, 2013
1832013
The system can't perform the operation now. Try again later.
Articles 1–20